A preclinical-stage biopharmaceutical company dedicated to the discovery and development of innovative treatments for immuno-oncology. #Drugdiscovery #GPCR #IO
Strasbourg
Joined December 2012
- Tweets488
- Following45
- Followers344
- Likes67
Domain Therapeutics retweeted
The French-Canadian firm @DOMAINtx raised an impressive €39M in Series A to tackle cancer by blocking G protein-coupled receptors. The company aims to create a new class of immune checkpoint inhibitors, cancer drugs that revolutionized cancer treatment. bit.ly/3wJKFcf
Domain Therapeutics retweeted
📣 We're pleased to contribute to the building of @DOMAINtx - alongside important partners in the #LifeSciences ecosystem - by joining a $42M USD Series A investment to transform the company's immuno-oncology programs into cancer treatments. admarebio.com/admare-bioinno…
Domain Therapeutics retweeted
[Life Science portfolio]👏@ Congrats! @DOMAINtx for the $42m Series A financing ow.ly/VW2250J4WxE #immuno_oncology #cancer
Domain Therapeutics retweeted
📢 Le 13 mai, lors de notre PhDMeeting "Jobs in #Oncology", @DOMAINtx organise un speed-meeting de 14h à 17h sur la plateforme @PhDTalent !
Ils sont à la recherche d'un #docteur en immuno-#oncologie !
Pour y candidater :
👉 bit.ly/3FeOPN9
Domain Therapeutics retweeted
IRICoR is delighted with the announcement made today by ONO PharmaceuticalCo., Ltd., on signing a collaboration agreement with @DOMAINtx and @UMontreal, to discover new small molecules targeting #GPCRs in the treatment of a #metabolicdisease.
bit.ly/37zcI5w
Domain Therapeutics retweeted
@adMare_Bio annonce les candidats retenus pour l’Institut des sciences de la vie pour cadres supérieurs en 2021-2022 >> zcu.io/777i
🎉Plusieurs membres BIOQuébec feront partie de la cohorte 2021-2022👏
@medicagoinc @RepareRx @DOMAINtx @ModelisLabs @CoolestHotspot
Domain Therapeutics retweeted
#PhD, @DOMAINtx recrute un #docteur en #biologie ou en #pharmacologie !
Si vous êtes intéressés, vous pouvez consulter l'offre en détail sur la plateforme @PhDTalent et y postuler !
👉 bit.ly/3zNnj57 👈
#offre #Emploi #doctorant #jobs
Domain Therapeutics retweeted
#PhD, @DOMAINtx recrute !
Si vous êtes intéressés, vous pouvez consulter l'offre en détail sur la plateforme @PhDTalent et y postuler !
👉 bit.ly/3okfdyV 👈
#offre #Emploi #doctorant #jobs
Domain Therapeutics retweeted
#PhD, @DOMAINtx recrute !
Si vous êtes intéressés, vous pouvez consulter l'offre en détail sur la plateforme @PhDTalent et y postuler !
👉 bit.ly/3AztlaA 👈
#offre #Emploi #doctorant #jobs
Domain Therapeutics retweeted
It’s not too late to register for @DrGPCR summit talk by Dr. Meriem Semache @DOMAINtx on bioSensAll®, an enhanced bystander BRET technology to advance #GPCR drug discovery. Register #drgpcr @TwistBioscience #GPCR_Therapeutics @livecellassays @abs_yn eventbrite.com/e/16634157713…
Domain Therapeutics retweeted
It’s not too late to register for @DrGPCR summit talk by Dr. Meriem Semache @Domaintx on bioSensAll®, an enhanced bystander BRET technology to advance #GPCR drug discovery. Register #drgpcr @TwistBioscience #GPCR_Therapeutics @livecellassays @abs_yn eventbrite.com/e/16634157713…
Domain Therapeutics retweeted
June 4, Virtual #Symposium: #GPCRs In #Oncology & #Immuno-oncology
Meet the speakers:
Martine J. Smit @VUamsterdam
Xavier Leroy @DOMAINtx
@CarrenoSeb @med_umontreal
@SilvioGutkind @UCSDHealth
@Michel_Bouvier
@ErnestNetwork
-> bit.ly/3u2Hg59
youtube.com/watch?v=y4akVluW…
Domain Therapeutics retweeted
Working and collaborating with the team from @IRIC_umontreal and @DOMAINtx for the upcoming #Immunooncology symposium on June 4 has been so rewarding. Register and join the free event on #gpcr research: bit.ly/3tKOIRY
@DOMAINtx , a leading #GPCR company in immuno-oncology, is proud to sponsor @IRIC_umontreal #Symposium : GPCRs In #Oncology & #Immunooncology. This event will showcase how #GPCRs can be strategic target to deliver innovative therapeutic approaches.
youtube.com/watch?v=x2bwB1wk…
Domain Therapeutics retweeted
Register for the Virtual Symposium: GPCRs In Oncology & Immuno-oncology, on June 4!
The event will showcase some of the latest discoveries and techniques leveraging the potential of GPCRs in these crucial fields.
The event is free and open to all: bit.ly/2RcytzU
Domain Therapeutics retweeted
[Portefeuille Sciences de la Vie] Immuno-oncologie : Domain Therapeutics débute les études précliniques réglementaires pour l’entrée en phase I de son programme antagoniste du récepteur EP4 ow.ly/JjRh50CHDtP @DOMAINtx
Domain Therapeutics retweeted
[ALA client in the news] @DOMAINtx monte en puissance avec l'américain @pfizer #GPCR lesechos.fr/pme-regions/inno…
Domain Therapeutics retweeted
Several #postdocs positions @DOMAINtx Immunology, IO, GPCRs, Immune-checkpoints, Antibodies, Target engagement, Biomarkers, Med Chem, ... 2 years Marie Skłodowska-Curie Action Individual Fellowship (MSCA-IF).
lnkd.in/eurkwTE
#immunooncology #gprs #checkpoint
Domain Therapeutics retweeted
#maladies rares #medicament : 2 entreprises alsaciennes @DOMAINtx et PeptiMimesis co-fondent Find Therapeutics. Une belle union ancrée sur une techno @InsermEst @unistra propulsée par @ConectusAlsace. Merci au talentueux chercheur Dominique Bagnard ! bit.ly/2C6HJxG
